StockClub

QNCX

QNCXQuince Therapeutics, Inc.$ --
Quince Therapeutics, Inc.

Quince Therapeutics, Inc.

QNCX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-11M USD
YoY +25.2%
Net Income
36M USD
YoY +338.9%
EPS
7.17$
YoY +310.9%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$35.9M
FY2024 Q2$-38.9M
$-38.9M
Q2
FY2024 Q3$-44.4M
$-44.4M
Q3
FY2024 Q4$-56.8M
$-56.8M
Q4
FY2025 Q1$-15M
$-15M
Q1
FY2025 Q2$-31.1M
$-31.1M
Q2
FY2025 Q3$-44.5M
$-44.5M
Q3
FY2025 Q4$-84M
$-84M
Q4
FY2026 Q1$35.9M
$35.9M
Q1
Actual
+$50.9M (+338.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025IN-LINE
Actual:$0
Est:$0
FY2025IN-LINE
$0

Analyst Estimates